Ventyx Biosciences Inc (VTYX)

Q: Does VTYX pay dividends?

Ventyx Biosciences Inc (VTYX) does not currently pay a regular dividend.

Official site

BIOTECHNOLOGY

$14.00

+0.00 (+0.00%)

Last updated: Mar 04, 2026 at 4:00 PM ET

Earnings

Performance (10Y)

Beat Rate

71%(12/17)

Avg Surprise

-34.89%

Streak

8 Q

Last 12 of 21 reported quarters

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Sep 30, 2025Sep 25 Reported Nov 7, 2025Reported Nov 7	$-0.32	$-0.45	$-0.58 - $-0.39	+28.89%	Beat	6	6 0 30d	+36.0%
Jun 30, 2025Jun 25 Reported Aug 7, 2025Reported Aug 7	$-0.38	$-0.46	$-0.57 - $-0.39	+17.39%	Beat	7	3 2 30d	+15.6%
Mar 31, 2025Mar 25 Reported Jun 5, 2025Reported Jun 5	$-0.39	$-0.69	$-0.77 - $-0.65	+43.48%	Beat	6	1 0 30d	+37.1%
Dec 31, 2024Dec 24 Reported Feb 27, 2025Reported Feb 27	$-0.41	$-0.54	$-0.62 - $-0.44	+24.26%	Beat	7	0 1 30d	+48.1%
Sep 30, 2024Sep 24 Reported Nov 4, 2024Reported Nov 4	$-0.50	$-0.52	$-0.62 - $-0.43	+3.85%	Beat	8	No revisions (30d)	+45.7%
Jun 30, 2024Jun 24 Reported Aug 9, 2024Reported Aug 9	$-0.45	$-0.58	$-0.69 - $-0.50	+22.41%	Beat	8	No revisions (30d)	+50.5%
Mar 31, 2024Mar 24 Reported May 9, 2024Reported May 9	$-0.62	$-0.69	$-0.86 - $-0.38	+10.14%	Beat	8	No revisions (30d)	+8.8%
Dec 31, 2023Dec 23 Reported Feb 27, 2024Reported Feb 27	$-0.79	$-0.90	$-1.47 - $-0.85	+12.22%	Beat	9	No revisions (30d)	-27.4%
Sep 30, 2023Sep 23 Reported Nov 9, 2023Reported Nov 9	$-0.92	$-0.90	$-1.07 - $-0.72	-2.22%	Miss	9	No revisions (30d)	-55.9%
Jun 30, 2023Jun 23 Reported Aug 10, 2023Reported Aug 10	$-0.91	$-0.71	$-0.78 - $-0.65	-28.17%	Miss	9	No revisions (30d)	-133.3%
Mar 31, 2023Mar 23 Reported May 11, 2023Reported May 11	$-0.68	$-0.65	$-0.71 - $-0.59	-4.62%	Miss	8	No revisions (30d)	-51.1%
Dec 31, 2022Dec 22 Reported Mar 23, 2023Reported Mar 23	$-0.62	$-0.64	$-0.91 - $-0.43	+3.13%	Beat	10	No revisions (30d)	-72.2%

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	N/A	Operating Margin	N/A
ROE	N/A	ROIC	N/A
Financial Health
Debt/Equity	N/A	Interest Coverage	N/A
Current Ratio	N/A	Quick Ratio	N/A
Trading Statistics
Beta	N/A	Avg Volume	N/A
52-Week High	N/A	52-Week Low	N/A

Technical Indicators Dashboard

Moving Averages

SMA 10$13.97

SMA 20$13.96

SMA 50$12.84

SMA 200$6.40

EMA 10$13.97

EMA 20$13.86

EMA 50$12.71

EMA 200$7.79

MACD

Line: 0.27Signal: 0.37Hist: -0.10

ADX

ADX: 70.3+DI: 50.0-DI: 8.1

Aroon & PSAR

Aroon Up100.0

Aroon Down28.0

PSAR$20.31

Bollinger Bands

Upper Band$14.00

Lower Band$13.92

%B Position61%(Middle)

Band Width0.97

RSI (14-Day)

Overbought

72.6

Momentum Oscillators

Stoch %K92.2

Stoch %D82.7

Williams %RN/A

ROC (10d)0.3%

Momentum0.04

CCI (20d)185.6

MFI (14d)70.9

Volatility Measures

ATR (14d)$0.15(1.1%)

StdDev (20d)0.02

Hist Vol2.1%(Low)

Volume Flow

VWAP$14.00

OBV248.9M

AD Line-88.2M

CMF (20d)-0.070

Volume Metrics

Avg Vol (20d)3.3M

Vol RatioN/A

VWMA (20d)$13.96

Pivot Points

R3$14.01

R2$14.01

R1$14.00

Pivot Point$14.00

S1$13.99

S2$13.99

S3$13.98

Advanced Oscillators

TSI45.28

Ultimate Osc48.7

KST96.78

Financial Data

Quarter	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022
Total Revenue	$0	$0	$0	$1.45M	$0	$0	$0	$1.08M	$0	$0	$0	$0
Cost of Revenue	$0	$0	$0	N/A	$0	$0	$0	$403,000	$0	$0	$0	$150,000
Gross Profit	$0	$0	$0	$724,000	$0	$0	$0	$673,000	$0	$0	$0	$-150,000

Operating Expenses	$24.87M	$29.33M	$30.10M	$32.42M	$38.55M	$35.71M	$41.77M	$50.35M	$57.95M	$57.15M	$42.55M	$38.57M
R&D	$17.71M	$22.27M	$22.90M	$24.82M	$30.63M	$27.80M	$33.75M	$42.02M	$49.75M	$48.56M	$35.44M	$30.18M
SG&A	$7.17M	$7.07M	$7.20M	$7.60M	$7.92M	$7.91M	$8.02M	$8.33M	$8.20M	$8.59M	$7.12M	$8.39M
Operating Income	$-24,874,000	$-29,333,000	$-30,097,000	$-32,418,000	$-38,552,000	$-35,712,000	$-41,768,000	$-50,346,000	$-57,951,000	$-57,145,000	$-42,552,000	$-38,571,000

Interest Income	$2.06M	$2.37M	$2.67M	$3.06M	$3.35M	$3.78M	$3.23M	$3.62M	$3.93M	$3.90M	$3.62M	$3.19M
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Income Before Tax	$-22,829,000	$-26,987,000	$-27,440,000	$-29,351,000	$-35,249,000	$-31,950,000	$-38,572,000	$-46,753,000	$-54,027,000	$-53,251,000	$-38,931,000	$-35,214,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-22,829,000	$-26,987,000	$-27,440,000	$-29,351,000	$-35,249,000	$-31,950,000	$-38,572,000	$-46,753,000	$-54,027,000	$-53,251,000	$-38,931,000	$-35,214,000

EBITDA	$-24,558,000	$-29,031,000	$-29,750,000	$-32,103,000	$-38,290,000	$-35,417,000	$-41,391,000	$-49,943,000	$-57,694,000	$-57,011,000	$-42,419,000	$-38,249,000
EBIT	$-24,884,000	$-29,354,000	$-30,106,000	$-32,418,000	$-38,599,000	$-35,733,000	$-41,799,000	$-50,346,000	$-57,959,000	$-57,150,000	$-42,553,000	$-38,399,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about VTYX

News

No news available

Company news will appear here when available

VTYX Competitors

Company	Ticker
Castle Biosciences Inc	CSTL
QuidelOrtho Corp	QDEL
CureVac NV	CVAC
MoonLake Immunotherapeutics	MLTX
Si-Bone Inc	SIBN
Janux Therapeutics Inc	JANX
Integra LifeSciences Holdings	IART
Harrow Health Inc	HROW

Sector: Healthcare

VTYX Bull Case vs Bear Case

Bull case

VTYX beat EPS estimates in 100.0% of its last 8 reported quarters.

VTYX Earnings: Beat Rate and Next Report

Beat rate: 8 of 8 quarters (100.0%)
Average surprise: 20.3%

VTYX ETF Holders

GNG tracks 2 ETFs that hold VTYX. The largest weights:

Schwab U.S. Broad Market ETF (SCHB), <0.01% of the fund
Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund

Open the ETF Stock Exposure tool for VTYX

See insider activity

Frequently Asked Questions About VTYX

Does VTYX pay dividends?